BioNTech SE American Depositary Share (BNTX) Next Earnings Date & Options-Implied ±7% Move
BioNTech SE American Depositary Share (BNTX) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Options-Implied Post-Earnings ±7% Bell Curve
Will BNTX Beat & Rip or Miss Next Quarter?
Trailing EPS: $2.71 • YoY Revenue Growth: 14.3%
Whale Flow & Momentum Playbook: Trading BNTX & AI Leaders Without Chasing Tops
- ✓Exact institutional whale strikes & implied earnings range on BNTX this week
- ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
- ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
BNTX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +14.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BNTX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BNTX. Explore sector supply chains on /butterfly.
BNTX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is BNTX's next earnings date?
Based on SEC filing cadence, BioNTech SE American Depositary Share (BNTX)'s next quarterly earnings window is estimated around Upcoming Quarter.
How much is BNTX stock expected to move on earnings?
Options markets currently imply a ±7% post-earnings move for BNTX, projecting a trading range between $82.89 and $95.37.